C264H338CoN116O83S16 — CID 172962338
octakis(N'-aminomethanimidamide);cobalt;N,N-diethyl-4-[(E)-2-(3-ethyl-3-methyl-1-propylindol-1-ium-2-yl)ethenyl]-3-methoxyaniline;4-[(E)-2-(1,3-diethyl-3-methylindol-1-ium-2-yl)ethenyl]-N,N-diethyl-3-methoxyaniline;octakis(N-(2,4-dihydroxyphenyl)iminomethanimidamide);bis(3-hydroxy-4-[(5-nitro-1,3-thiazol-3-id-2-ylidene)hydrazinylidene]cyclohexa-2,5-dien-1-one);heptakis(4-[(5-nitro-1,3-thiazol-2-yl)diazenyl]benzene-1,3-diol);heptakis((5-nitro-1,3-thiazol-2-yl)hydrazine);pentadecakis(propan-2-one) (PubChem CID 172962338) has the molecular formula C264H338CoN116O83S16 and a molecular weight of 7036.34 g/mol. Its IUPAC name is octakis(N'-aminomethanimidamide);cobalt;N,N-diethyl-4-[(E)-2-(3-ethyl-3-methyl-1-propylindol-1-ium-2-yl)ethenyl]-3-methoxyaniline;4-[(E)-2-(1,3-diethyl-3-methylindol-1-ium-2-yl)ethenyl]-N,N-diethyl-3-methoxyaniline;octakis(N-(2,4-dihydroxyphenyl)iminomethanimidamide);bis(3-hydroxy-4-[(5-nitro-1,3-thiazol-3-id-2-ylidene)hydrazinylidene]cyclohexa-2,5-dien-1-one);heptakis(4-[(5-nitro-1,3-thiazol-2-yl)diazenyl]benzene-1,3-diol);heptakis((5-nitro-1,3-thiazol-2-yl)hydrazine);pentadecakis(propan-2-one).
| Compound Name | octakis(N'-aminomethanimidamide);cobalt;N,N-diethyl-4-[(E)-2-(3-ethyl-3-methyl-1-propylindol-1-ium-2-yl)ethenyl]-3-methoxyaniline;4-[(E)-2-(1,3-diethyl-3-methylindol-1-ium-2-yl)ethenyl]-N,N-diethyl-3-methoxyaniline;octakis(N-(2,4-dihydroxyphenyl)iminomethanimidamide);bis(3-hydroxy-4-[(5-nitro-1,3-thiazol-3-id-2-ylidene)hydrazinylidene]cyclohexa-2,5-dien-1-one);heptakis(4-[(5-nitro-1,3-thiazol-2-yl)diazenyl]benzene-1,3-diol);heptakis((5-nitro-1,3-thiazol-2-yl)hydrazine);pentadecakis(propan-2-one) |
|---|---|
| PubChem CID | 172962338 |
| Molecular Formula | C264H338CoN116O83S16 |
| Molecular Weight | 7036.34 g/mol |
| Exact Mass | 7031.07 |
| IUPAC Name | octakis(N'-aminomethanimidamide);cobalt;N,N-diethyl-4-[(E)-2-(3-ethyl-3-methyl-1-propylindol-1-ium-2-yl)ethenyl]-3-methoxyaniline;4-[(E)-2-(1,3-diethyl-3-methylindol-1-ium-2-yl)ethenyl]-N,N-diethyl-3-methoxyaniline;octakis(N-(2,4-dihydroxyphenyl)iminomethanimidamide);bis(3-hydroxy-4-[(5-nitro-1,3-thiazol-3-id-2-ylidene)hydrazinylidene]cyclohexa-2,5-dien-1-one);heptakis(4-[(5-nitro-1,3-thiazol-2-yl)diazenyl]benzene-1,3-diol);heptakis((5-nitro-1,3-thiazol-2-yl)hydrazine);pentadecakis(propan-2-one) |
| SMILES | CC(C)=O.CC(C)=O.CC(C)=O.CC(C)=O.CC(C)=O.CC(C)=O.CC(C)=O.CC(C)=O.CC(C)=O.CC(C)=O.CC(C)=O.CC(C)=O.CC(C)=O.CC(C)=O.CC(C)=O.CCC[N+]1=C(/C=C/c2ccc(N(CC)CC)cc2OC)C(C)(CC)c2ccccc21.CCN(CC)c1ccc(/C=C/C2=[N+](CC)c3ccccc3C2(C)CC)c(OC)c1.N/C=N\N.N/C=N\N.N/C=N\N.N/C=N\N.N/C=N\N.N/C=N\N.N/C=N\N.N/C=N\N.NNc1ncc([N+](=O)[O-])s1.NNc1ncc([N+](=O)[O-])s1.NNc1ncc([N+](=O)[O-])s1.NNc1ncc([N+](=O)[O-])s1.NNc1ncc([N+](=O)[O-])s1.NNc1ncc([N+](=O)[O-])s1.NNc1ncc([N+](=O)[O-])s1.O=C1C=CC(=NN=c2[n-]cc([N+](=O)[O-])s2)C(O)=C1.O=C1C=CC(=NN=c2[n-]cc([N+](=O)[O-])s2)C(O)=C1.O=[N+]([O-])c1cnc(/N=N/c2ccc(O)cc2O)s1.O=[N+]([O-])c1cnc(/N=N/c2ccc(O)cc2O)s1.O=[N+]([O-])c1cnc(/N=N/c2ccc(O)cc2O)s1.O=[N+]([O-])c1cnc(/N=N/c2ccc(O)cc2O)s1.O=[N+]([O-])c1cnc(/N=N/c2ccc(O)cc2O)s1.O=[N+]([O-])c1cnc(/N=N/c2ccc(O)cc2O)s1.O=[N+]([O-])c1cnc(/N=N/c2ccc(O)cc2O)s1.[Co].[H]/N=C/N=N/c1ccc(O)cc1O.[H]/N=C/N=N/c1ccc(O)cc1O.[H]/N=C/N=N/c1ccc(O)cc1O.[H]/N=C/N=N/c1ccc(O)cc1O.[H]/N=C/N=N/c1ccc(O)cc1O.[H]/N=C/N=N/c1ccc(O)cc1O.[H]/N=C/N=N/c1ccc(O)cc1O.[H]/N=C/N=N/c1ccc(O)cc1O |
| InChI | InChI=1S/C27H37N2O.C26H35N2O.9C9H6N4O4S.8C7H7N3O2.7C3H4N4O2S.15C3H6O.8CH5N3.Co/c1-7-19-29-24-14-12-11-13-23(24)27(5,8-2)26(29)18-16-21-15-17-22(20-25(21)30-6)28(9-3)10-4;1-7-26(5)22-13-11-12-14-23(22)28(10-4)25(26)18-16-20-15-17-21(19-24(20)29-6)27(8-2)9-3;9*14-5-1-2-6(7(15)3-5)11-12-9-10-4-8(18-9)13(16)17;8*8-4-9-10-6-2-1-5(11)3-7(6)12;7*4-6-3-5-1-2(10-3)7(8)9;15*1-3(2)4;8*2-1-4-3;/h11-18,20H,7-10,19H2,1-6H3;11-19H,7-10H2,1-6H3;2*1-4H,(H2,10,12,14,15);7*1-4,14-15H;8*1-4,8,11-12H;7*1H,4H2,(H,5,6);15*1-2H3;8*1H,3H2,(H2,2,4);/q2*+1;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;/p-2/b;;;;7*12-11+;8*8-4+,10-9+;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;; |
| InChIKey | ZLNBAJOYVNLJSM-XLMHQGSYSA-L |
| XLogP | 49.89 |
| TPSA | 3260.00 Ų |
| H-Bond Donors | 70 |
| H-Bond Acceptors | 179 |
| Rotatable Bonds | 72 |
| Heavy Atoms | 480 |
| Complexity | — |
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 7036.34 |
| LogP ≤ 5 | 49.89 |
| H-Bond Donors ≤ 5 | 70 |
| H-Bond Acceptors ≤ 10 | 179 |